Targeting the cGAS-STING pathway as an inflammatory crossroad in coronavirus disease 2019 (COVID-19)
Authors:
- 19 June 2023
- journal article
- review article
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 45 (6) , 639-649
Abstract
Context and objective: The emerging pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has imposed significant mortality and morbidity on the world. An appropriate immune response is necessary to inhibit SARS-CoV-2 spread throughout the body.Results: During the early stages of infection, the pathway of stimulators of interferon genes (STING), known as the cGAS-STING pathway, has a significant role in the induction of the antiviral immune response by regulating nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and Interferon regulatory factor 3 (IRF3), two key pathways responsible for proinflammatory cytokines and type I IFN secretion, respectively.Discussion: During the late stages of COVID-19, the uncontrolled inflammatory responses, also known as cytokine storm, lead to the progression of the disease and poor prognosis. Hyperactivity of STING, leading to elevated titers of proinflammatory cytokines, including Interleukin-I (IL-1), IL-4, IL-6, IL-18, and tissue necrosis factor-α (TNF-α), is considered one of the primary mechanisms contributing to the cytokine storm in COVID-19.Conclusion: Exploring the underlying molecular processes involved in dysregulated inflammation can bring up novel anti-COVID-19 therapeutic options. In this article, we aim to discuss the role and current studies targeting the cGAS/STING signaling pathway in both early and late stages of COVID-19 and COVID-19-related complications and the therapeutic potential of STING agonists/antagonists. Furthermore, STING agonists have been discussed as a vaccine adjuvant to induce a potent and persistent immune response.Keywords
This publication has 108 references indexed in Scilit:
- Single Nucleotide Polymorphisms of Human STING Can Affect Innate Immune Response to Cyclic DinucleotidesPLOS ONE, 2013
- cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STINGNature, 2013
- Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic AcidThe Journal of Immunology, 2013
- The Ubiquitin Ligase TRIM56 Regulates Innate Immune Responses to Intracellular Double-Stranded DNAImmunity, 2010
- Pattern Recognition Receptors and InflammationCell, 2010
- Stimulator of IFN Gene Is Critical for Induction of IFN-β during Chlamydia muridarum InfectionThe Journal of Immunology, 2010
- STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunityNature, 2009
- STING is an endoplasmic reticulum adaptor that facilitates innate immune signallingNature, 2008
- DNase 1 and systemic lupus erythematosusAutoimmunity Reviews, 2008
- Immunomodulatory Actions of Xanthenone Anticancer AgentsBioDrugs, 1997